Urinary bile acids as biomarkers for liver diseases II. Signature profiles in patients.
about
CYP3A Specifically Catalyzes 1β-Hydroxylation of Deoxycholic Acid: Characterization and Enzymatic Synthesis of a Potential Novel Urinary Biomarker for CYP3A Activity.Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans.Can BSEP Inhibition Testing In Drug Discovery And Development Reduce Liver Injury Risk? - An International Transporter Consortium PerspectiveBile Acids as Potential Biomarkers to Assess Liver Impairment in Polycystic Kidney Disease
P2860
Urinary bile acids as biomarkers for liver diseases II. Signature profiles in patients.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Urinary bile acids as biomarkers for liver diseases II. Signature profiles in patients.
@en
Urinary bile acids as biomarkers for liver diseases II. Signature profiles in patients.
@nl
type
label
Urinary bile acids as biomarkers for liver diseases II. Signature profiles in patients.
@en
Urinary bile acids as biomarkers for liver diseases II. Signature profiles in patients.
@nl
prefLabel
Urinary bile acids as biomarkers for liver diseases II. Signature profiles in patients.
@en
Urinary bile acids as biomarkers for liver diseases II. Signature profiles in patients.
@nl
P2093
P2860
P356
P1476
Urinary bile acids as biomarkers for liver diseases II. Signature profiles in patients.
@en
P2093
Marco Olivera
Nagsen Gautam
Rhishikesh Thakare
Sai Praneeth R Bathena
Sandeep Mukherjee
Yazen Alnouti
P2860
P304
P356
10.1093/TOXSCI/KFU228
P577
2014-10-24T00:00:00Z